BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 10, 2006
View Archived Issues
CancerVax, Micromet Enter $127M Merger Agreement
In a transaction that augments one company's pipeline and gives the other U.S. market access, CancerVax Corp. and Micromet AG signed a definitive merger agreement. (BioWorld Today)
Read More
Replidyne Submits NDA For Oral Antibiotic Drug Orapem
Read More
More Good Phase III Results With Celgene's Thalidomide
Read More
Xytis Series B: $25M For Trials In Schizophrenia, Brain Injury
Read More
Other News To Note
Read More